Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Idea Of The Day -- Ignore unavailable to you. Want to Upgrade?

To: IQBAL LATIF who wrote (30888)	3/15/2000 4:14:00 AM
From: Toni Wheeler	Read Replies (1) \| Respond to of 50167

Ike, this explanation of the biotech "smashing" is an example of "kneejerk reaction" by sellers: fool.com Today's Real News: Government Supports Gene Patents How investors are misunderstanding biotech By Jeff Fischer (TMF Jeff) March 14, 2000 <<<People fell all over themselves to sell biotech shares today, even though many of these same people had rushed to buy the shares only recently. Human Genome Sciences (Nasdaq: HGSI) , Celera (NYSE: CRA) , Millennium Pharmaceuticals (Nasdaq: MLNM) , Incyte (Nasdaq: INCY) and many other young, leading biotech stocks fell 20% or greater. The culprit? The media is pointing to Bill Clinton and the U.K.'s Tony Blair. The two men had the "audacity" to propose that raw human genome sequencing information should be shared with the public. That is not new information, however. The Human Genome Project was created long ago to do this very thing (share its information), and since its inception Celera stated that it would likely share its raw data for free or at very little cost to subscribers. So, in fact, the only novel news presented today was good news, thus it is baffling that biotech shares got stomped....>>>(more) My best, T.